FDA to Speed Review of Generic Drug Applications Until It’s Approved Three of Them
From the article:
The Food and Drug Administration on Tuesday moved to try to spur more competition in the market for generic drugs, an effort aimed at driving down prices.
In a policy change, the agency will now fast-track applications for generic drugs until three of them have been approved for a given medication. And in a broadcast to manufacturers about what it’s looking for, the FDA also published a list of about 170 categories of old drugs without generics, ranging from a glaucoma drug to the penicillin antibiotic amoxicillin.
Read the full article here.bioethics fda health law policy pharmaceuticals public health rachel sachs regulation